TWA
TCI Wealth Advisors’s Pacira BioSciences PCRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-43
| Closed | -$1.66K | – | 2606 |
|
2022
Q4 | $1.66K | Hold |
43
| – | – | ﹤0.01% | 2015 |
|
2022
Q3 | $2K | Sell |
43
-155
| -78% | -$7.21K | ﹤0.01% | 1968 |
|
2022
Q2 | $12K | Hold |
198
| – | – | ﹤0.01% | 911 |
|
2022
Q1 | $15K | Hold |
198
| – | – | ﹤0.01% | 840 |
|
2021
Q4 | $12K | Buy |
198
+90
| +83% | +$5.46K | ﹤0.01% | 1043 |
|
2021
Q3 | $6K | Buy |
108
+22
| +26% | +$1.22K | ﹤0.01% | 1476 |
|
2021
Q2 | $5K | Buy |
86
+14
| +19% | +$814 | ﹤0.01% | 1450 |
|
2021
Q1 | $5K | Buy |
72
+29
| +67% | +$2.01K | ﹤0.01% | 1273 |
|
2020
Q4 | $3K | Hold |
43
| – | – | ﹤0.01% | 1095 |
|
2020
Q3 | $3K | Hold |
43
| – | – | ﹤0.01% | 968 |
|
2020
Q2 | $2K | Buy |
+43
| New | +$2K | ﹤0.01% | 1084 |
|
2020
Q1 | – | Sell |
-43
| Closed | -$2K | – | 1673 |
|
2019
Q4 | $2K | Buy |
+43
| New | +$2K | ﹤0.01% | 1175 |
|